Bradley Cross
Family Medicine · McAlester, OKNPI 1932639572
Payments from drug & device makers
Across 295 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$696
- Novo Nordisk$626
- GSK$619
- Pfizer$434
- Lilly USA, LLC$216
- Boehringer Ingelheim$192
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,49599%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $696 |
| Novo Nordisk | 38 | $626 |
| GSK | 43 | $619 |
| Pfizer | 34 | $434 |
| Lilly USA, LLC | 15 | $216 |
| Boehringer Ingelheim | 10 | $192 |
| Amarin Pharma, Inc. | 8 | $187 |
| AstraZeneca | 12 | $182 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $163 |
| Sanofi-aventis U.S. LLC | 10 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $119 |
| Sumitomo Pharma America, Inc. | 6 | $114 |
| Mylan Specialty L.p. | 5 | $112 |
| Eisai Inc. | 3 | $91 |
| Sunovion Pharmaceuticals Inc. | 5 | $83 |
| Johnson & Johnson | 6 | $83 |
| Astellas Pharma US Inc | 3 | $60 |
| Biogen | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Amgen | 3 | $45 |
| Exact Sciences | 2 | $30 |
| Alk-abello, Inc | 2 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Beckman Coulter, Inc. | 1 | $20 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $11 |
How this compares
$4,535 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 16 | $21,259 |
| EliquisApixaban | 17 | $15,972 |
| OzempicSemaglutide | 13 | $14,421 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,722 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $7,677 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,186 |
| MovantikNaloxegol Oxalate | 14 | $3,069 |
| Celecoxib | 22 | $2,507 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $2,255 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $2,041 |
| Divalproex Sodium | 30 | $1,588 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,360 |
| Gabapentin | 71 | $1,308 |
| Potassium Chloride | 52 | $1,083 |
| SynthroidLevothyroxine Sodium | 21 | $918 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $192 | $21,25916 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $619 | $18,39836 claims |
| PfizerEliquis | $434 | $15,97217 claims |
| Novo NordiskOzempic | $626 | $14,42113 claims |
| AstraZenecaSymbicort | $182 | $4,18619 claims |
| AbbVieSynthroid | $696 | $91821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in McAlester
- Carl GriffinOklahoma City$28.2M
- Lisa ConneryNorman$15.6M
- Kyle RicknerYukon$14.7M
- Robert LockwoodYukon$8.6M
- Steven CoxNorman$6.9M
- Alexander FrankOklahoma City$3.1M
- Rachel AndersonNorman$2.8M
- Robert WestcottLindsay$1.6M
- Charles LunnOklahoma City$1.4M
- Jeffrey ChasteenTulsa$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.